Adherence to bone health guidelines in patients with hormone receptor-positive early breast cancer: Status and clinical impact in a Swiss cohort experience

AIM: In patients with postmenopausal hormone receptor-positive breast cancer (ER + eBC), aromatase inhibitors (AIs) are widely used for effective relapse prevention. However, AIs reduce bone density and increase bone-related events (BREs). Alongside calcium and vitamin D3 supplementation, bisphospho...

Descripción completa

Detalles Bibliográficos
Autores principales: Bischof, Evelyne, Schwab, Fabienne D., Georgescu Margarint, Elena Laura, Montavon, Céline, Zünti, Iris, Schollbach, Anna, Schötzau, Andreas, Hirschmann, Anna, Landin, Julia, Meier, Christian, Christian, Kurzeder, Vetter, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685978/
https://www.ncbi.nlm.nih.gov/pubmed/34977282
http://dx.doi.org/10.1016/j.bonr.2021.101160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8685978/
https://www.ncbi.nlm.nih.gov/pubmed/34977282
http://dx.doi.org/10.1016/j.bonr.2021.101160

Ejemplares similares